- Welldoc and Redox announce a partnership to ensure bidirectional integration with EHR with Welldoc’s digital health solution for diabetes management, BlueStar.
- This partnership will allow providers to receive and review insights about users of Welldoc’s BlueStar digital health app for diabetes management directly within their EHR at the point of care.
Welldoc, a digital health company revolutionizing chronic disease management, announced today its strategic partnership with Redox Inc., the leading interoperability platform for healthcare data exchange. The partnership will allow providers to receive and review insights about users of the BlueStar® digital health app for diabetes management directly within their EHR at the point of care.
Optimizing Clinical Decision Support with Real-Time Patient Data
With a shared vision to improve health outcomes of patients and alleviate physician burden, Welldoc and Redox are positioned to optimize clinical decision support by making more patient data available in real-time. This is critical for patients managing a chronic disease.
Welldoc’s digital health tools work with the Redox network to ensure products are capable and securely executing meaningful, bidirectional integration workflows with a vendor-agnostic platform for healthcare data exchange. Today, more than 600 healthcare organizations using 45 EHR vendors trust Redox to strategically integrate digital health solutions into their day-to-day operations. Through this partnership, Welldoc’s BlueStar is immediately interoperable with any organization using Redox for healthcare data exchange to optimize the provider and patient experience.
Why It Matters
With one in four American adults managing multiple chronic conditions today, patients are seeking ways to better self-manage health outside of the clinical setting. BlueStar provides precise, AI-based real-time feedback focused on engaging patients to manage their health with clinical decision support.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
BlueStar® was the first FDA-cleared digital health solution that guides individuals through the complicated journey of living with diabetes. By helping individuals with chronic disease self-manage their conditions and connecting them to their own healthcare team, Welldoc streamlines payers, employers and healthcare systems resources by focusing on a digital health solution to help better manage their populations living with multiple and costly chronic diseases.
“Digital therapeutics done right is a godsend for patients managing a chronic disease,” said Luke Bonney, co-founder and CEO of Redox. “The power of a caregiver in your pocket 24/7 cannot be overstated. Welldoc is fundamentally changing the way patients live with diabetes and establishing a standard for the industry with a commitment to integrations with CGMs, wearables, and EHRs. We are excited and proud to be a part of Welldoc’s mission and to ensure that the actionable insights derived by the BlueStar platform are made available to providers in an optimal way.”
Source: Hit Consultant